Provided by Tiger Trade Technology Pte. Ltd.

Amneal Pharmaceuticals, Inc.

17.78
-0.1300-0.73%
Volume:1.79M
Turnover:31.81M
Market Cap:5.67B
PE:36.98
High:17.92
Open:17.81
Low:17.61
Close:17.91
52wk High:19.26
52wk Low:9.20
Shares:319.00M
Float Shares:182.33M
Volume Ratio:1.16
T/O Rate:0.98%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.4808
EPS(LYR):0.2200
ROE:613.02%
ROA:8.60%
PB:171.75
PE(LYR):80.82

Loading ...

Barclays Sticks to Their Buy Rating for Amneal Pharmaceuticals (AMRX)

TIPRANKS
·
Mar 18

What Amneal Pharmaceuticals (AMRX)'s Return to Profitability and 2026 Guidance Means For Shareholders

Simply Wall St.
·
Mar 11

Amneal’s Chirag Patel to Join Fireside Chat at Barclays Annual Global Healthcare Conference

Reuters
·
Mar 06

Goldman Sachs Reaffirms Their Buy Rating on Amneal Pharmaceuticals (AMRX)

TIPRANKS
·
Mar 05

Amneal Pharmaceuticals Is Maintained at Buy by Truist Securities

Dow Jones
·
Mar 02

Truist Adjusts Price Target on Amneal Pharmaceuticals to $17 From $15, Maintains Buy Rating

MT Newswires Live
·
Mar 02

Amneal Pharmaceuticals price target raised to $17 from $15 at Truist

TIPRANKS
·
Mar 02

Truist ups Amneal Pharmaceuticals price target, says pullback great entry point

TIPRANKS
·
Feb 28

Stock Track | Amneal Pharmaceuticals Plummets 5.04% Intraday Despite Q4 Beat as 2026 Revenue Guidance Disappoints

Stock Track
·
Feb 28

GUIDANCE: (AMRX) Amneal Pharmaceuticals Expects 2026 Adjusted EPS Range $0.93 to $1.03, vs. FactSet Est of $0.94

MT Newswires Live
·
Feb 27

Amneal Q4 net revenue rises 11% to USD 814 million

Reuters
·
Feb 27

Amneal Pharmaceuticals Q4 Adj. EPS $0.21 Beats $0.18 Estimate, Sales $814.319M Beat $807.895M Estimate

Benzinga Earnings
·
Feb 27

Amneal Pharmaceuticals Outlook FY Revenue USD 3,050-3,150 Million

THOMSON REUTERS
·
Feb 27

Amneal Pharmaceuticals Q4 Gross Profit USD 297.19 Million

THOMSON REUTERS
·
Feb 27

Amneal Pharmaceuticals Outlook FY Adjusted Ebitda USD 720-760 Million

THOMSON REUTERS
·
Feb 27

Amneal Pharmaceuticals Q4 Pretax Profit USD 55.235 Million

THOMSON REUTERS
·
Feb 27

Amneal Reports Fourth Quarter and Full Year 2025 Financial Results

THOMSON REUTERS
·
Feb 27

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Feb 27

U.S. Earnings Preview: Before Market Open Feb. 27

Dow Jones
·
Feb 27